Skip to content

Dexmedetomidine Infusion Effect on Hemodynamic Variables During Craniotomy

Efficacy of Dexmedetomidine Infusion Without Loading Dose on Hemodynamic Variables and Recovery Time During Craniotomy: A Randomized Double Blinded Controlled Study

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04607525
Enrollment
40
Registered
2020-10-29
Start date
2020-11-21
Completion date
2021-01-26
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodynamic Instability, Supratentorial Neoplasms

Keywords

Postoperative analgesia, Craniotomy, Dexmedetomidine

Brief summary

There is no clear consensus among neuroanesthesiologists regarding which anesthetic regimen is optimal for craniotomy. Propofol and short-acting opioids (such as remifentanil, fentanyl, or sufentanil) are commonly used. However, use of opioids is associated with increased risk of respiratory depression and postoperative nausea and vomiting. Dexmedetomidine is a highly selective α2-adrenoreceptor agonist that has been considered as a useful and safe adjunct to anesthesia for various surgical procedures

Detailed description

The investigators designed this randomized, double-blind study to evaluate the effectiveness of administration of Dexmedetomidine infusion at a dose of 0.5 µg/kg/h without loading dose during elective supratentorial craniotomy under GA. The investigators will compare intraoperative hemodynamics in both groups, intraoperative analgesic consumption, intraoperative blood loss, postoperative sedation scores, intraoperative need for rescue hypotensive agents, and finally the satisfaction of surgeons. To our knowledge, the present study is the first to evaluate the effect of Dexmedetomidine infusion without loading dose in elective supratentorial craniotomy

Interventions

DRUGDexmedetomidine

On the scheduled time of operation, the head nurse opened each envelope just before surgery, prepared the infusion solution and handled it to the anesthesiologist who was blinded to the solution. He was then determined for collecting perioperative data. Group D: Patients received 0.5 µg/kg/h of Dexmedetomidine. Dexmedetomidine dosage was diluted in 50 ml syringe of normal saline Group C: Patients received equal volume and rate of normal saline as Group D. This dosing regimen was in accordance with existing guidelines \[5\] \[6\] \[7\].

DRUGnormal saline

On the scheduled time of operation, the head nurse opened each envelope just before surgery, prepared the infusion solution and handled it to the anesthesiologist who was blinded to the solution. He was then determined for collecting perioperative data. Group C: Patients received equal volume and rate of normal saline as Group D.

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* American society of anesthesiologists- Physical status (ASA-PS) I and II patients, * aged 18 to 65 years * 70-80 kg * both sexes * undergoing elective supratentorial craniotomy for tumor resection

Exclusion criteria

* Patients under 18 years of age * pregnancy, * emergency surgery * patients with a Glasgow Coma Score (GCS) less than 15. * Those who had respiratory or cardiac dysfunction, renal insufficiency, liver impairment, or bleeding disorders

Design outcomes

Primary

MeasureTime frameDescription
Mean areterial blood pressure4 to 8 hoursincidence of intraoperative hemodynamic stability
Heart rate4 to 8 hoursincidence of intraoperative hemodynamic stability
Number of Participants needed rescue agents4 to 8 hours

Secondary

MeasureTime frameDescription
Recovery time in minutesAt the end of operationRecovery time in minutes (time interval between discontinuation of isoflurane and extubation).
Postoperative sedation level1st 2 hours postoperativelyAssessment of postoperative sedation level using University of Michigan Sedation Scale (UMSS) The UMSS is a simple observational tool that assesses the level of alertness on a five-point scale ranging from 1 (wide awake) to 5 (unarousable with deep stimulation). Score: 1- 5

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026